Where the medicines of tomorrow are evaluated today.


Do you suffer from GERD?

Gastroesophageal Reflux disease (GERD) is a very common condition that develops when the reflux of stomach contents causes troublesome symptoms and/or complications. GERD is defined as having at least weekly heartburn and/or regurgitation. The term GERD covers a broad spectrum of conditions including Erosive Esophagitis (EE). EE is an acid-related disorder and is diagnosed by endoscopic examination that reveals redness and/or a break in the mucosal lining of the esophagus.

Despite having the availability of prescription and over-the-counter medications, the management of GERD remains a problem. About 40% of people report continued issues with symptoms and maintenance of healing.

The purpose of this study is to determine the healing and maintenance of healing comparing an FDA-approved medication (Prevacid) to a research medication. Participants will undergo an endoscopic exam (EGD) to determine the presence of EE and a repeat EGD to evaluate healing.

What does the study involve?

If the screening EGD is positive for EE, the participant will receive study medication. Repeat EGDs will be performed to evaluate healing. The total number of visits and EGDs will be based upon healing. The study can be up to 7 visits and compensation is up to $1200. The study medicaiton, laboratory and diagnostic testing, and physical exams are at no charge.

Who qualifies to participate?

To qualify to participate, you must be:

  • 18 years of age or older
  • Willing to undergo an endoscopic exam
  • Basically healthy with no active ulcers or GI bleed in prior 30 days
  • Not planning a hospitalization or surgical procedure

How do I participate?

For more information and to see if you may be eligible to participate, call 615-329-2222 or click the PARTICIPATE button.